Literature DB >> 29058314

T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.

P Kumar1,2, P Misra1, C P Thakur3, A Saurabh1,2, N Rishi2, D K Mitra1.   

Abstract

Visceral leishmaniasis (VL) is a disseminated and lethal disease of reticulo-endothelial system caused by protozoan parasites Leishmania donovani and L. infantum, which are known to induce host T cell suppression. To understand the impact of parasite load on T cell function, the present was focused on parasite load with T cell function in bone marrow of 26 VL patients. We observed significant enrichment of forkhead box protein 3 (FoxP3)+ (P = 0·0003) and interleukin (IL)-10+ FoxP3+ regulatory T cells (Treg ) (P = 0·004) in the bone marrow (BM) of patients with high parasite load (HPL) compared with low parasite load (LPL). Concordantly, T effector cells producing interferon (IFN)-γ (P = 0·005) and IL-17A (P = 0·002) were reduced in the BM of HPL. Blocking of Treg -cell derived suppressive cytokines [(IL-10 and transforming growth factor (TGF)-β] rescued the effector T cells and their functions. However, it was observed that TGF-β levels were dominant, favouring Treg cell differentiation. Furthermore, the low ratio of IL-6/TGF-β favours the suppressive milieu in HPL patients. Here we show the change in levels of various cytokines with the parasitic load during active VL, which could be helpful in devising newer immunotherapeutic strategies against this disease.
© 2017 British Society for Immunology.

Entities:  

Keywords:  Leishmania donovani; T regulatory cells (Treg); bone marrow aspirate (BMA); visceral leishmaniasis (VL)

Mesh:

Substances:

Year:  2017        PMID: 29058314      PMCID: PMC5801524          DOI: 10.1111/cei.13074

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

2.  Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis.

Authors:  M Abdus Salam; M Gulam Musawwir Khan; Khondaker Rifat Hasan Bhaskar; Mokibul Hassan Afrad; M Mamun Huda; Dinesh Mondal
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

4.  Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis.

Authors:  Ambak K Rai; Chandreshwar P Thakur; Amar Singh; Tulika Seth; Sandeep K Srivastava; Pushpendra Singh; Dipendra K Mitra
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

5.  Vaccine Development Against Leishmania donovani.

Authors:  Amrita Das; Nahid Ali
Journal:  Front Immunol       Date:  2012-05-15       Impact factor: 7.561

6.  Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.

Authors:  Shirin Sayyahfar; Shahla Ansari; Mehdi Mohebali; Babak Behnam
Journal:  Korean J Parasitol       Date:  2014-04-18       Impact factor: 1.341

7.  Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients.

Authors:  Eltahir Awad Gasim Khalil; Selma Abdelmoneim Khidir; Ahmed Mudawi Musa; Brema Younis Musa; Mona Elfaki Eltahir Elfaki; Abdelgadir Mohamed Yousif Elkadaru; Edward Zijlstra; Ahmed Mohamed El-Hassan
Journal:  J Trop Med       Date:  2013-03-24

8.  Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection.

Authors:  Yegnasew Takele; Tamrat Abebe; Teklu Weldegebreal; Asrat Hailu; Workagegnehu Hailu; Zewdu Hurissa; Jemal Ali; Ermiyas Diro; Yifru Sisay; Tom Cloke; Manuel Modolell; Markus Munder; Fabienne Tacchini-Cottier; Ingrid Müller; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

9.  Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.

Authors:  Pradyot Bhattacharya; Smriti Ghosh; Sarfaraz Ahmad Ejazi; Mehebubar Rahaman; Krishna Pandey; Vidya Nand Ravi Das; Pradeep Das; Rama Prosad Goswami; Bibhuti Saha; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2016-02-01

Review 10.  Regulation of immunity during visceral Leishmania infection.

Authors:  Vasco Rodrigues; Anabela Cordeiro-da-Silva; Mireille Laforge; Ricardo Silvestre; Jérôme Estaquier
Journal:  Parasit Vectors       Date:  2016-03-01       Impact factor: 3.876

View more
  4 in total

1.  Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis.

Authors:  Prabin Kumar; Pragya Misra; Narendra Kumar Yadav; Sumit Joshi; Amogh A Sahasrabuddhe; Anuradha Dube; Narayan Rishi; Dipendra Kumar Mitra
Journal:  Trop Parasitol       Date:  2019-05-22

Review 2.  Emerging patterns of regulatory T cell function in tuberculosis.

Authors:  A Ahmed; A Vyakarnam
Journal:  Clin Exp Immunol       Date:  2020-09-06       Impact factor: 4.330

3.  Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis.

Authors:  Lorranny Santana Rodrigues; Aline Silva Barreto; Lays Gisele Santos Bomfim; Marcos Couto Gomes; Nathalia Luisa Carlos Ferreira; Geydson Silveira da Cruz; Lucas Sousa Magalhães; Amélia Ribeiro de Jesus; Clarisa B Palatnik-de-Sousa; Cristiane Bani Corrêa; Roque Pacheco de Almeida
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

4.  Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.

Authors:  Sarra Hamrouni; Rachel Bras-Gonçalves; Abdelhamid Kidar; Karim Aoun; Rym Chamakh-Ayari; Elodie Petitdidier; Yasmine Messaoudi; Julie Pagniez; Jean-Loup Lemesre; Amel Meddeb-Garnaoui
Journal:  PLoS Negl Trop Dis       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.